ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE(R) SL Self-Loading MHC Class I Monomers. The novel reagents for antigen-specific CD8+ ...

ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility: Oxford, England Saturday, November 1, 2025, 14:00 Hrs [IST] ProImmune Ltd, a ...

ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers.

In recognition of Pancreatic Cancer Awareness Month, join us to explore how cutting-edge technologies are transforming our ...

ProImmune has announced the launch of its ProVE SL Self-Loading MHC Class I Monomers, a new reagent platform designed to enhance antigen-specific CD8+ T cell detection. The Oxford-based life science ...

Gross margins in the third quarter of 2025 were approximately 48.5%, versus 54.9% in the third quarter of 2024; and non-GAAP ...

A team of researchers has identified a previously unrecognized hub for waste clearance in the human brain, located along a major artery supplying the brain’s protective outer layer. This discovery, ...

Standard Biotools Inc ( ($LAB) ) has released its Q3 earnings. Here is a breakdown of the information Standard Biotools Inc presented to its ...

A 56-year-old man was admitted to the hospital because of left lower abdominal pain and anemia. He had a 1-year history of ...

Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., ...